Delivery Order SPE2DB24D2101-SPE2DB25FKNXP
Award Date 8/26/25
Potential Completion Date 9/17/25
Potential Value $7.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $17,777.00 for 100 mg vials of Enhertu, a oncology therapeutic agent used in cancer treatment. This firm fixed-price, competitively awarded contract was issued by the Defense Logistics Agency Medical Supply Chain on August 14, 2025, with a completion date of September 5, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child...
- The Defense Logistics Agency awarded a $17,777.00 delivery order to AmerisourceBergen Drug Corp for 100 milligram vials of Enhertu, a specialty oncology medication. This firm fixed price contract, issued on May 30, 2025, with an ultimate completion date of June 23, 2025, represents a child order under AmerisourceBergen's larger pharmaceutical supply agreements with the federal government. The award was competitively granted without set-aside provisions and will be performed at...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $12,443.90 for 100 mg vials of Enhertu, a oncology therapeutic agent, with performance in Conshohocken, Pennsylvania and completion scheduled for May 13, 2025. This competitively awarded, firm fixed-price delivery order contains no set-aside designation and represents a child contract under AmerisourceBergen's larger pharmaceutical supply framework with the federal government. This delivery order executes...
- The Defense Logistics Agency awarded a delivery order valued at $8,888.50 to AmerisourceBergen Drug Corp for the supply of Enhertu 100 mg vials, with an ultimate completion date of October 9, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the prime contractor. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order is issued...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,777.70 to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Enhertu 100 mg vials, a specialized pharmaceutical product. The contract is firm fixed price with an ultimate completion date of August 11, 2025, and will be performed at the vendor's location in Conshohocken, Pennsylvania. This award is a non-set-aside competitive procurement, reflecting AmerisourceBergen's capability to meet federal pharmaceutical...
- The Defense Logistics Agency awarded a $17,777.00 firm fixed price delivery order to AmerisourceBergen Drug Corp for 100 mg vials of Enhertu, a oncology therapeutic medication used in cancer treatment. The contract was competitively awarded without a set-aside designation and is scheduled for completion by October 8, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion prime...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $10,666.20 for 100 mg vials of Enhertu, an oncology medication, on September 8, 2025, with completion scheduled for September 29, 2025. This non-competitive delivery order represents a firm fixed-price transaction issued under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion pharmaceutical prime vendor agreement running through December...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 100 mg vials of Enhertu, a specialty pharmaceutical product, with a ceiling value of $7,110.80. This firm fixed-price delivery order was competitively awarded without set-aside provisions and is scheduled for completion by September 29, 2025. The award leverages AmerisourceBergen's established Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion global...
- The Defense Logistics Agency awarded a $10,666.20 delivery order to AmerisourceBergen Drug Corp for 100 mg vials of Enhertu, a prescription oncology medication used in cancer treatment. This firm fixed-price delivery order, issued on August 13, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The award was made through open competition with no set-aside...
- This is a $16,117.70 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the supply of Enhertu 100 mg vials, a specialty pharmaceutical product, with a performance period through August 28, 2024. Amerisourcebergen is a leading pharmaceutical distributor that holds multiple indefinite delivery contracts (IDCs) with the DLA and other federal agencies to provide a wide range of medical...